teriflunomide accord
accord healthcare s.l.u. - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresívami, selektívne imunosupresívami - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
bozilos
egis pharmaceuticals plc, maďarsko - teriflunomid - 59 - immunopraeparata
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemické prípravky - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
teriflunomide stada 14 mg filmom obalené tablety
stada arzneimittel ag, nemecko - teriflunomid - 59 - immunopraeparata
teriflunomide g.l. pharma 14 mg filmom obalené tablety
g.l. pharma gmbh, rakúsko - teriflunomid - 59 - immunopraeparata
clefirem
bausch health ireland limited , Írsko - teriflunomid - 59 - immunopraeparata
terebyo 14 mg
sandoz pharmaceuticals d.d., slovinsko - teriflunomid - 59 - immunopraeparata
boxarid 14 mg filmom obalené tablety
gedeon richter plc., maďarsko - teriflunomid - 59 - immunopraeparata
teriflunomide zentiva
zentiva, k.s., Česká republika - teriflunomid - 59 - immunopraeparata
teriflago 14 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - teriflunomid - 59 - immunopraeparata